234 related articles for article (PubMed ID: 20215518)
41. Period 2 mutation accelerates ApcMin/+ tumorigenesis.
Wood PA; Yang X; Taber A; Oh EY; Ansell C; Ayers SE; Al-Assaad Z; Carnevale K; Berger FG; Peña MM; Hrushesky WJ
Mol Cancer Res; 2008 Nov; 6(11):1786-93. PubMed ID: 19010825
[TBL] [Abstract][Full Text] [Related]
42. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
43. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc
Saxena A; Tammali R; Ramana KV; Srivastava SK
Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349
[TBL] [Abstract][Full Text] [Related]
44. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
Buchanan FG; Holla V; Katkuri S; Matta P; DuBois RN
Cancer Res; 2007 Oct; 67(19):9380-8. PubMed ID: 17909047
[TBL] [Abstract][Full Text] [Related]
45. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
[TBL] [Abstract][Full Text] [Related]
46. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
47. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
Nandan MO; Ghaleb AM; McConnell BB; Patel NV; Robine S; Yang VW
Mol Cancer; 2010 Mar; 9():63. PubMed ID: 20298593
[TBL] [Abstract][Full Text] [Related]
48. Conjugated linoleic acids differentially alter polyp number and diameter in the Apc(min/+) mouse model of intestinal cancer.
Mandir N; Goodlad RA
Cell Prolif; 2008 Apr; 41(2):279-91. PubMed ID: 18336472
[TBL] [Abstract][Full Text] [Related]
49. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
50. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
Ding S; McEntee MF; Whelan J; Zemel M
Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
[TBL] [Abstract][Full Text] [Related]
51. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
53. Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc(Min/+) mouse.
Murphy EA; Davis JM; McClellan JL; Carmichael MD
Nutr Cancer; 2011; 63(3):421-6. PubMed ID: 21391122
[TBL] [Abstract][Full Text] [Related]
54. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.
Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S
Cancer Res; 2003 Mar; 63(5):895-901. PubMed ID: 12615699
[TBL] [Abstract][Full Text] [Related]
55. Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice.
Noma N; Fujii G; Miyamoto S; Komiya M; Nakanishi R; Shimura M; Tanuma SI; Mutoh M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420165
[TBL] [Abstract][Full Text] [Related]
56. Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice.
Mehl KA; Davis JM; Clements JM; Berger FG; Pena MM; Carson JA
J Appl Physiol (1985); 2005 Jun; 98(6):2219-25. PubMed ID: 15894538
[TBL] [Abstract][Full Text] [Related]
57. Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice.
Yang K; Lamprecht SA; Shinozaki H; Fan K; Yang W; Newmark HL; Kopelovich L; Edelmann W; Jin B; Gravaghi C; Augenlicht L; Kucherlapati R; Lipkin M
J Nutr; 2008 Sep; 138(9):1658-63. PubMed ID: 18716166
[TBL] [Abstract][Full Text] [Related]
58. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
59. Chemopreventive effect of 4'-hydroxychalcone on intestinal tumorigenesis in
Chen Q; Lei J; Zhou J; Ma S; Huang Q; Ge B
Oncol Lett; 2021 Mar; 21(3):213. PubMed ID: 33510814
[TBL] [Abstract][Full Text] [Related]
60. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms.
Tanaka T; Kohno H; Suzuki R; Hata K; Sugie S; Niho N; Sakano K; Takahashi M; Wakabayashi K
Int J Cancer; 2006 Jan; 118(1):25-34. PubMed ID: 16049979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
